You searched for metabolic diseases - Page 56 of 64

News and Trends 19 May 2022

Evotec, Sernova in partnership to develop beta cell diabetes therapy

…lost beta cells has long been a focus for diabetes research. In 2010, Evotec acquired DeveloGen, a metabolic disease company and spinout from the Max-Planck Institute in Germany that had…

May 19, 2022 - 3 minutesmins - By Susannah Rodgers

In Depth 14 Feb 2024

The next leap in pet health: longevity drugs for dogs

…dogs’ metabolic health to delay the onset and reduce the impact of age-associated diseases. “It’s a little bit more of a reversal mechanism. It’s not going to make a 10-year-old…

February 14, 2024 - 7 minutesmins - By Willow Shah-Neville

News and Trends 12 Feb 2018

Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide

Swiss pharma Roivant has given French biotech Poxel €28M upfront to get involved with the development and commercialization of imeglimin, a new treatment for metabolic disorders like type 2 diabetes….

February 12, 2018 - 3 minutesmins - By Alex Dale

News and Trends 29 May 2020

AI Drug Discovery Firm Exscientia Closes €54M Series C

…for an undisclosed rare metabolic disease. “The opportunities the platform gives us are broad, hence such joint ventures enable us to scale the pipeline by combining our drug discovery platform…

May 29, 2020 - 3 minutesmins - By David Kirk

News and Trends 22 Jun 2023

FDA approves type 2 diabetes drug for children 10 and older

…improve outcomes for this population and supports our larger commitment to advance treatment options for people living with a range of cardiometabolic conditions.” Jardiance is not recommended in patients with…

June 22, 2023 - 3 minutesmins - By Jim Cornall

Orchard therapeutics gene therapy header

News and Trends 1 Nov 2018

Gene Therapy Company’s IPO Shoots it to Billion-Euro Biotech List

Orchard Therapeutics, a British company developing gene therapy for rare genetic diseases, has launched its Nasdaq IPO and is now reportedly worth $1.25B (€1B). This IPO propels Orchard to the…

November 1, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 15 Sep 2021

UK Startup Surfs Investment Wave in Microbiome with €18M Series A

…The technology could potentially tackle a plethora of seemingly unrelated diseases, including infections, metabolic disorders, and cancer. The Scottish investment firm Thairm Bio led the financing, with US-based Kineticos Ventures…

September 15, 2021 - 4 minutesmins - By Anita Chakraverty

News and Trends 17 Oct 2017

Genfit Gets €180M Cash Injection to Bring its Pipeline to Market

…therapeutics for metabolic and inflammatory diseases. Its lead candidate, elafibranor, targets Non-Alcoholic Stato-Hepatitis (NASH) – an inflammatory disease of the liver. The company has raised €180M by selling bonds that…

October 17, 2017 - 3 minutesmins - By Alex Dale

News and Trends 1 Oct 2018

Cancer-Sniffing Diagnostics Company Secures €43.1M Funding

…other diseases such as tuberculosis, asthma, and inflammatory bowel disease. For example, GSK showed interest in the device last year, using it in a clinical trial of its treatment for…

October 1, 2018 - 2 minutesmins - By Jonathan Smith

More News! 21 Dec 2022

Watch: Aphaia Pharma interview

…metabolic disorders such as obesity and associated diseases. Aphaia Pharma’s lead candidate, APH-012, a glucose formulation, has been shown to safely restore endogenous hormone release in individuals with obesity. APH-012…

December 21, 2022 - 1 minutemin - By Jim Cornall

News and Trends 14 Apr 2016

European Biotech teams up with US Navy to engineer Military Materials

…light, and BacHBerry, to bio-mine the metabolic diversity of berries – an increasingly popular strategy. Biotechnology is increasingly being used to develop smarter materials, from biodegradable bioplastics from potatoes to…

April 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 3 Apr 2020

Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M

…cell growth through targeting metabolic pathways has the potential to deliver new approaches to treat a wide range of severe diseases.” The UK company has only shared minimal information about…

April 3, 2020 - 2 minutesmins - By Helen Albert

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Evotec, Sernova in partnership to develop beta cell diabetes therapy

The next leap in pet health: longevity drugs for dogs

Healthcare-Biotech Partnership Pledges to Take its Type 2 Diabetes Treatment Worldwide

AI Drug Discovery Firm Exscientia Closes €54M Series C

FDA approves type 2 diabetes drug for children 10 and older

Gene Therapy Company’s IPO Shoots it to Billion-Euro Biotech List

UK Startup Surfs Investment Wave in Microbiome with €18M Series A

Genfit Gets €180M Cash Injection to Bring its Pipeline to Market

Cancer-Sniffing Diagnostics Company Secures €43.1M Funding

Watch: Aphaia Pharma interview

European Biotech teams up with US Navy to engineer Military Materials

Lilly Partners UK Immunometabolism Biotech in Deal Worth €811M

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!